CXCR6 Protein-VLP

Produktnummer ABIN7489101

Produktdetails

Target: CXCR6 (Chemokine (C-X-C Motif) Receptor 6 (CXCR6))

Protein-Typ: VLP

Spezies: Human

Quelle: HEK-293 Cells

Verwendungszweck: Human CXCR6 / CD186 Full Length Protein (VLP)

Sequenz: Ala 2 - Leu 342

Produktmerkmale: Human CXCR6 Full Length Protein (VLP) is expressed from human 293 cells (HEK293). It contains AA Ala 2 - Leu 342 (Accession # O00574-1).

Endotoxin-Niveau: 1.0 EU per μg

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, Arginine, pH 7.4

Lagerung: -80 °C

Informationen zur Lagerung: -70°C

Antigendetails

Target: CXCR6 (Chemokine (C-X-C Motif) Receptor 6 (CXCR6))

Andere Bezeichnung: CXCR6 (CXCR6 Produkte)

Synonyme: BONZO Protein, CD186 Protein, STRL33 Protein, TYMSTR Protein, BB217514 Protein, C-X-C motif chemokine receptor 6 Protein, chemokine (C-X-C motif) receptor 6 L homeolog Protein, chemokine (C-X-C motif) receptor 6 Protein, CXCR6 Protein, cxcr6.L Protein, Cxcr6 Protein

Hintergrund: The protein encoded by this gene is a G protein-coupled receptor with seven transmembrane domains that belongs to the CXC chemokine receptor family. This family also includes CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, and CXCR7. This gene, which maps to the chemokine receptor gene cluster, is expressed in several T lymphocyte subsets and bone marrow stromal cells. The encoded protein and its exclusive ligand, chemokine ligand 16 (CCL16), are part of a signalling pathway that regulates T lymphocyte migration to various peripheral tissues (the liver, spleen red pulp, intestine, lungs, and skin) and promotes cell-cell interaction with dendritic cells and fibroblastic reticular cells. CXCR6/CCL16 also controls the localization of resident memory T lymphocytes to different compartments of the lung and maintains airway resident memory T lymphocytes, which are an important first line of defense against respiratory pathogens. The encoded protein serves as an entry coreceptor used by HIV-1 and SIV to enter target cells, in conjunction with CD4. [provided by RefSeq, Aug 2020]